Abstract:Histone deacetylases (HDACs) are a superfamily of enzymes that catalyze the removal of acetyl functional groups from lysine residues of histone and non-histone proteins. There are 18 mammalian HDACs, which are classified into four classes based on the primary homology with yeast HDACs. Among these groups, Class I and II HDACs play a major role in lysine deacetylation of the N-terminal histone tails. In mammals, HDACs play a pivotal role in the regulation of gene transcription, cell growth, survival, and proliferation. HDACs regulate the expression of inflammatory genes, as evidenced by the potent anti-inflammatory activity of pan-HDAC inhibitors, which were implicated in several pathophysiologic states in the inflammation process. However, it is unclear how each of the 18 HDAC proteins specifically contributes to the inflammatory gene expression. It is firmly established that inflammation and its inability to converge are central mechanisms in the pathogenesis of several cardiovascular diseases (CVDs). Emerging evidence supports the hypothesis that several different pro-inflammatory cytokines regulated by HDACs are associated with various CVDs. Based on this hypothesis, the potential for the treatment of CVDs with HDAC inhibitors has recently begun to attract attention. In this review, we will briefly discuss (1) pathophysiology of inflammation in cardiovascular disease, (2) the function of HDACs in the regulation of atherosclerosis and cardiovascular diseases, and (3) the possible therapeutic implications of HDAC inhibitors in cardiovascular diseases. Recent studies reveal that histone deacetylase contributes critically to mediating the pathophysiology of inflammation in cardiovascular disease. HDACs are also recognized as one of the major mechanisms in the regulation of inflammation and cardiovascular function. HDACs show promise in developing potential therapeutic implications of HDAC inhibitors in cardiovascular and inflammatory diseases.

Regulation of cardiovascular diseases by histone deacetylases and NADPH oxidases

Histone Deacetylases in Modulating Cardiac Disease and Their Clinical Translational and Therapeutic Implications

Dysregulation of Histone Acetyltransferases and Deacetylases in Cardiovascular Diseases.

Histone deacetylases: Regulation of vascular homeostasis via endothelial cells and vascular smooth muscle cells and the role in vascular pathogenesis

Research Advances of Histone Deacetylase and Cardiovascular Diseases

Critical Functions of Histone Deacetylases (HDACs) in Modulating Inflammation Associated with Cardiovascular Diseases

The role of class IIa histone deacetylases in regulating endothelial function

Targeting histone deacetylase in cardiac diseases

NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets

Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis.

Histone Methylation and Oxidative Stress in Cardiovascular Diseases.

Targeting Histone Deacetylases: Perspectives for Epigenetic-Based Therapy in Cardio-Cerebrovascular Disease

Histone Deacetylases (hdacs) and Atherosclerosis: A Mechanistic and Pharmacological Review

Targeting histone deacetylases for heart diseases

[Research Progress in NADPH Oxidase Family in Cardiovascular Diseases].

Histone Deacetylase 3: A Potential Therapeutic Target for Atherosclerosis

The expression and function of NADPH oxidase in common cardiovascu-lar diseases

The Role of NADPH Oxidases in Cardiovascular Disease

Cellular and molecular biology of posttranslational modifications in cardiovascular disease

The Nrf-2/HO-1 Signaling Axis: A Ray of Hope in Cardiovascular Diseases

NAD<SUP>+</SUP> and cardiovascular diseases